Overview

The Therapy Effect of Azathioprine Initial or 14 Weeks After Combined With Infliximab on CD

Status:
Unknown status

Trial end date:
2019-07-01

Target enrollment:
0

Participant gender:
All

Summary

This study aim to identify the therapeutic effect of azathioprine during infliximab(IFX) treatment in Crohn's disease (CD).Half of patients will receive azathioprine and infliximab combination therapy at the same time. The other half patients will be given infliximab therapy first and then receive azathioprine 14 weeks later.

Phase:

N/A

Accepts Healthy Volunteers?

Details

Lead Sponsor:

Sixth Affiliated Hospital, Sun Yat-sen University

Treatments:

Azathioprine
Infliximab

Criteria

Inclusion Criteria:

- CD patients need infliximab and azathioprine combination therapy

Exclusion Criteria:

- patients had lost response to infliximab or azathioprine previously patients intolerable
to infliximab or azathioprine patients need to use 5-Aminosalicylates(5-ASA) patients had
participated to other clinical study in two months